Skip to main content

Eukles Asset Management

Position in NVO — Novo Nordisk A S

CIK 1632553 CINCINNATI, OH

Position in NVO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,408,649
+$537,082 QoQ
Shares Held
50,243
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#346
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Eukles Asset Management holds $4,968,554 across 5 Drug Manufacturers - General names. NVO ranks #1 (48.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
50,243 $2,408,649

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,408,649 50,243
2026-03-31 $1,871,567 50,927
2025-12-31 $2,693,231 52,933
2025-09-30 $2,937,252 52,933
2025-06-30 $3,707,409 53,715
2025-03-31 $3,563,105 51,312
2024-12-31 $4,270,462 49,645
2024-09-30 $6,380,246 53,584
2024-06-30 $7,701,536 53,955
2024-03-31 $6,976,357 54,333
2023-12-31 $5,786,061 55,931
2023-09-30 $5,336,813 58,685
2023-06-30 $4,714,917 29,135
2023-03-31 $4,631,928 29,106
2022-12-31 $3,975,747 29,376
2022-09-30 $2,906,406 29,172
2022-06-30 $3,260,998 29,265
2022-03-31 $3,239,772 29,174
2021-12-31 $3,304,336 29,503
2021-09-30 $2,778,817 28,943
2021-06-30 $2,341,203 27,948
2021-03-31 $1,749,886 25,955
2020-12-31 $1,773,770 25,394
2020-09-30 $1,721,308 24,792
2020-06-30 $1,603,801 24,493
2020-03-31 $1,387,369 23,046